raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:972

Hereditary continuous muscle fiber activity

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant
Age of onset
Childhood, Infancy
Status
active

Hereditary continuous muscle fiber activity is a rare, non-dystrophic myopathy characterized by generalized myokymia and increased muscle tone associated with delayed motor milestones, leg stiffness, spastic gait, hyperreflexia and Babinski sign. Symptoms may be worsened by febrile illness or anesthesia.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enHereditary continuous muscle fiber activity
frActivité continue familiale de la fibre musculaire
deMuskuläre Daueraktivität, hereditäreIsaacs-Mertens-Syndrom
esActividad continua de la fibra muscular hereditaria
itAttività continua ereditaria delle fibre muscolari
nlErfelijke continue spiervezelactiviteit
ptAtividade contínua das fibras musculares hereditáriaSíndrome Isaacs-Mertens
plDziedziczna ciągła aktywność włókien mięśniowychZespół Isaacsa i Mertens
csDědičná kontinuální aktivita svalových vláken
ukСпадкова безперервна активність мязових волокон
zh遗传性持续肌纤维活动
trKalıtsal sürekli kas lifi aktivitesi

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM160120NTBTvalidated
ICD-10G71.1NTBTattributedvalidated
ICD-118C7YNTBTindexvalidated
MONDO0019943Evalidated
MeSHC563545Evalidated
UMLSC1834559Evalidated
GARD1512Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
KCNA1Disease-causing germline mutation(s) inAssessedHGNC:6218ENSG0000011126217626012p13.32potassium voltage-gated channel subfamily A member 117136396[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families34 casesWorldwideCase(s)Validated6703941[PMID]_17136396[PMID]_1170284[PMID]_9528033[PMID]_889293[PMID]_3504247[PMID]_1647493[PMID]_17136396[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidated6703941[PMID]_17136396[PMID]_1170284[PMID]_9528033[PMID]_889293[PMID]_3504247[PMID]_1647493[PMID]_17136396[PMID]_ORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

10 annotations · validated 2016-06-01
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0100022Abnormality of movement
HP:0003457EMG abnormality
HP:0003236Elevated circulating creatine kinase concentration
HP:0002064Spastic gait
HP:0003803Type 1 muscle fiber predominance
Frequent (79-30%)
HP:0001251Ataxia
HP:0001260Dysarthria
HP:0001350Slurred speech
Occasional (29-5%)
HP:0000776Congenital diaphragmatic hernia
HP:0001250Seizure

Run the differential on the 5 obligate / very frequent terms

7

Sources for this card